Related Experiment Video

Updated: Aug 21, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

New therapeutic agents for resistant Gram-positive infections

Hisham Ziglam1, Dillip Nathwani

  • 1Specialist Registrar in Infectious Diseases Infection and Immunodeficiency Unit, Tayside University Hospitals NHS Trust (TUHT), Dundee, DD1 9SY, UK. hziglam@doctors.org.uk

Expert Review of Anti-Infective Therapy
|October 16, 2004
PubMed

Insights

New antibiotics are needed to combat rising antibiotic resistance in Gram-positive bacteria. This review covers emerging treatments for serious infections caused by multidrug-resistant staphylococci, enterococci, and pneumococci.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Gram-positive bacteria are a growing cause of healthcare-associated infections.
  • Increasing antibiotic resistance, including in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), poses a significant threat.
  • There is an urgent need for novel antimicrobial agents to treat these resistant infections.

Purpose of the Study:

  • To review recently licensed and clinically developing agents for multidrug-resistant Gram-positive bacterial infections.
  • To focus on treatments for serious infections caused by MRSA, VRE, and resistant Streptococcus pneumoniae.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of clinical trial data for new antimicrobial agents.
  • Assessment of recently approved drugs for resistant Gram-positive pathogens.

Main Results:

  • Several classes of novel antimicrobial compounds are under development.
  • Emerging agents show promise in combating infections caused by resistant staphylococci, enterococci, and pneumococci.
  • The pipeline includes treatments addressing reduced glycopeptide susceptibility in MRSA.

Conclusions:

  • The development of new antimicrobial agents is crucial to address the increasing threat of multidrug-resistant Gram-positive bacteria.
  • Clinical development is progressing for agents targeting serious infections caused by resistant staphylococci, enterococci, and pneumococci.
  • Continued research and development are essential to stay ahead of evolving antibiotic resistance.

More Related Videos

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...